To elucidate whether RA475 binds to RPN13, we used Up284B as a probe and performed the labeling assay after treating ovarian cancer cell lysates (ES2 and SKOV3) in the presence of titrated doses of RA475 (unlabeled). This evidence concerns the gene ADRM1 and ovarian carcinoma.